The National Cancer Institute (NCI) offers this grant to facilitate well-planned clinical trials in cancer prevention and control. Its goal is to improve prevention, health behaviors, screening, early detection, healthcare delivery, symptom management, and long-term survivor outcomes. Investigators often lack critical information on study populations, accrual, interventions, or operational risks, causing costly protocol changes and delays. This grant funds preparatory studies to fill these gaps. By supporting rigorous planning and testing new trial designs, the program aims to enhance trial feasibility and design, ultimately saving NCI time and resources while ensuring more efficient research.
Opportunity ID: 356978
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-25-103 |
| Funding Opportunity Title: | Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.399 — Cancer Control |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 05, 2024 |
| Last Updated Date: | Nov 05, 2024 |
| Original Closing Date for Applications: | Oct 25, 2027 |
| Current Closing Date for Applications: | Oct 25, 2027 |
| Archive Date: | Nov 30, 2027 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses County governments Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments City or township governments Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Private institutions of higher education Special district governments Public housing authorities/Indian housing authorities |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this NOFO is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related symptoms, supportive care, and the long-term outcomes of cancer survivors. Although the scientific literature or preliminary data may provide the rationale for conducting a clinical trial, investigators often lack critical information about the study population, accrual challenges, intervention, outcome/ endpoints, data/statistical challenges or operational risks necessary to finalize the trial protocol completely. These information gaps can result in multiple protocol changes before and after trial start-up, leading to the need for additional time and expenses that may prevent study completion. Further, the suitability and feasibility of new trial designs, which minimize infrastructure and reduce costs may need to be tested in the context of a particular intervention, at-risk group, symptom or venue. Preparatory studies may fill information gaps and address unknowns, improving trial design and knowledge of trial feasibility and thus saving NCI time and money. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-25-103.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 356978 Full Announcement-PAR-25-103 -> PAR-25-103-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00288473 | Jan 25, 2025 | Oct 25, 2027 | View |
Package 1
Mandatory forms
356978 RR_SF424_5_0-5.0.pdf
356978 PHS398_CoverPageSupplement_5_0-5.0.pdf
356978 RR_OtherProjectInfo_1_4-1.4.pdf
356978 PerformanceSite_4_0-4.0.pdf
356978 RR_KeyPersonExpanded_4_0-4.0.pdf
356978 PHS398_ResearchPlan_5_0-5.0.pdf
356978 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
356978 RR_Budget_3_0-3.0.pdf
356978 RR_SubawardBudget30_3_0-3.0.pdf
356978 PHS398_ModularBudget_1_2-1.2.pdf
356978 PHS_AssignmentRequestForm_4_0-4.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
